From "Made in China" to "Developed in China." The VBInsight report, "China's Innovative Biopharma: Navigating the Global Market," details this strategic transformation. As of Dec 2024, China leads the world in original innovative drugs, with clinical trial efficiency steadily rising.
The future of biopharma innovation is here.

